C14-A1

• UNSPSC Description:

  C14-A1 is an ionizable cationic lipid that can be used to synthesize lipid nanoparticles (LNP) for delivering mRNA and other payloads[1].

• Target Antigen:

  Liposome

• Type:

  Reference compound

• Related Pathways:

  Metabolic Enzyme/Protease

• Field of Research:

  Inflammation/Immunology

• Assay Protocol:

  https://www.medchemexpress.com/c14-a1.html

• Smiles:

  OC(CCCCCCCCCCCC)CN(CCCCCN(CCN1CCN(CC1)CCCCCN(CC(O)CCCCCCCCCCCC)CC(CCCCCCCCCCCC)O)CC(O)CCCCCCCCCCCC)CC(CCCCCCCCCCCC)O

• Molecular Weight:

  1361.36

• References & Citations:

  [1]Ajay S Thatte, et al. mRNA Lipid Nanoparticles for Ex Vivo Engineering of Immunosuppressive T Cells for Autoimmunity Therapies. Nano Lett. 2023 Nov 22;23(22):10179-10188.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported